couter

DSOLDrug Free Solution, Inc.

Oct 15, 2026 — Estimated Q3 2026 Earnings Release
Chart by TradingView

The schedule

  • Thu15Oct

    DSOL faces its next estimated quarterly financial report. With current price anchoring at $0.0004, the print is expected to push shares to $0.0002 as going-concern risks mount, or to $0.0010 on unlikely restructuring hopes.

  • Fri4Dec

    From a $0.00 base price, persistent lack of reporting could trigger regulatory action by OTC Markets. Suspension drives shares to $0.0001, while avoiding action allows a minor bounce to $0.0005.

  • Thu18Feb

    From $0.0001, outstanding debt and negative equity may force aggressive convertible debt issuance, driving the price toward a terminal $0.00005 as dilution accelerates, though a clean restructuring could lift it to $0.0003.